In a candid episode of No Ordinary Subjects, I share my personal experience of being shortchanged in a migraine clinical trial after a technical error led to a missed blood draw. The sponsor's refusal to take responsibility sparked a crucial question: why don't patients have a public platform to review clinical trials like consumers review businesses? I break the silence naming the sponsor and offering a raw patient perspective on the study demanding transparency and accountability. This episode confronts ethical oversight FDA regulations and the undervaluation of trial participants. It's a call for change urging a shift towards patient empowerment and respect within clinical research. Listen now and share your story as we advocate for patients.

#patientadvocacy #healthcarepodcast #medicalpodcast #newepisode #patientrights #clinicaltrials #clinicalresearch #researchethics #FDA #drugdevelopment #pharmaceuticals #medicalresearch #studyparticipants #trialtransparency #clinicaltrialexperience #trialreview #researchaccountability #patientexperience #informedconsent #transparency #accountability #healthcaretransparency #corporateresponsibility #patientfeedback #consumerreviews #healthcarereviews #industryaccountability #patientcompensation #medicalmistakes #migrainestudy #technicalfailure #shortchanged #undervalued #healthcaredisparities #ethicaloversight #statusquochallenge #patientempowerment #patientvoice #changehealthcare #healthcarereform #jointheconversation.

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

In this solo episode of No Ordinary Subjects, I reflect on a topic close to my heart: patient compensation in clinical trials. Having stepped away from the industry, I share my candid thoughts on how the lack of respect for participants played a role in my decision. I have been an advocate for many years. A recent article by DIA brought the issue of money front and center: Compensation isn’t just financial— it’s a matter of ethics and fairness. Patients sacrifice time, health, and trust, yet their contributions continue to be undervalued in both figurative and literal ways. It’s time to reimagine clinical trials with empowerment and equity at the core. Let’s talk about what needs to change. #DIA #pharma #drugdevelopment #clinicaltrials #patient #participant #participation #clinicalresearch #financial #ethics #equity #sacrifice #decision #health #trust #compensation #playfair #transparency #researchpartner #FDA #IRB #coercion #empowerment 

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

Feeling stuck? Overwhelmed by where to begin? Both are more common than a cold. In this episode of No Ordinary Subjects, host Allison Kalloo dives into the power of taking that all-important first step toward your passion. Whether you’re launching a new project, pursuing a dream, or simply rethinking what’s possible, the message is clear: you don’t have to have it all figured out to get started.

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

As the year comes to a close, host Allison Kalloo reflects on the challenges, growth, and clarity 2024 brought while setting an inspiring tone for 2025. In this deeply personal episode, Allison shares stories from her journey, including lessons on communication and the power of human connection.

She dives into her multi-passionate goals: writing books, launching apps, designing CVSTOMOLOGY products, and more— showing how science and the arts can intersect to create meaningful impact. With a powerful call-to-action for the pharmaceutical and healthcare industries, Allison challenges listeners to stop the lip service and truly show up to make a difference.

This episode is more than a year-end reflection; it’s an invitation to explore your passions, embrace your purpose, and connect with yourself and others in transformative ways. Whether you’re chasing a dream or rethinking your impact, this conversation will leave you motivated to make 2024 your most intentional year yet.

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

In this episode of 'No Ordinary Subjects', we hear from 'Lady' Kimberly Anderson, whose breast cancer journey is a remarkable testament to both grace and grit. Diagnosed at the young age of 32, Lady Kimberly is forthcoming about her harrowing experience and what (and who) has kept her going in the 15 years since. She's happy to discuss the importance of leaning on family, faith, community, and a lot of creativity along the way. She shares her strong opinions across a variety a lot of topics, including chemotherapy, vaccines, and clinical trials. "More than a conqueror," she is an inspiration for how to live well with clarity and a sense of purpose. Don't miss this heartfelt episode. #heart #warrior #survivor #conqueror #breastcancer #straighttalk #clinicaltrials #clinicalresearch #support #faith #family #community #advocacy #creativity #survival #blessings #diagnosis #ambassador #USCongress #FDA #DEI #diversityguidance

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

The 2nd Annual Health Equity in Clinical Trials Congress took place in Atlanta, GA on May 8-9, 2024. I'm your podcast host, Allison Kalloo,  and I moderated the opening plenary session— a panel featuring patients like me! Not surprisingly, the time constraints did not allow for as robust a conversation as we would have liked, so it felt as if we were just scratching the surface of what we wanted to share with the audience of mostly pharma representatives. But... 'No Ordinary Subjects' seems like a great platform for taking a deeper dive. I also mention the #Medable digital eConsent as one of the potential solutions to the barriers we experience. [Full disclosure: I have served on Medable's Patient Advisory Council/Patient Caregiver Network for about 4 years.]  #HECT #pharma #clinicaltrials @HealthEquityCongress #healthequity #conference #health #equity #patient #participant #caregiver #network #FDA #research #clinicalresearch

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

On this episode of No Ordinary Subjects, host Allison Kalloo sits down with the remarkable Ms. Patricia Peele, a community activist and advocate from rural Halifax County, North Carolina. Patricia's story is one of inspiration and action, dedicated to increasing representation in clinical trials for Black, Brown, and rural communities. She shares her invaluable insights and practical advice for bridging the gap and fostering trust between researchers and these often-underrepresented populations. Patricia's firsthand experience as a research participant, coupled with her deep understanding of community needs, makes her a powerful voice in the fight for health equity. Join us as we explore the challenges and opportunities in clinical trial participation, and learn how we can work together to create a more inclusive and representative research landscape. Patricia's wisdom and passion are contagious, and this is an episode you won't want to miss. #ClinicalTrials #HealthEquity #DiversityInResearch #RuralHealth #CommunityEngagement #PatientAdvocacy #BlackHealth #BrownHealth #HealthDisparities #ResearchParticipation #InclusionInResearch #NoOrdinarySubjects #Podcast #HealthPodcast #NorthCarolina #HalifaxCounty #CommunityActivist #PatientExperience #RepresentationMatters #HealthResearch #MedicalResearch #ClinicalResearch

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

This extended, deeply personal episode of No Ordinary Subjects features a courageous conversation with a man who bravely shares his journey with lupus. For too long, lupus has been mistakenly perceived as a "women's disease," leaving men who experience it feeling isolated and misunderstood. Our anonymous guest opens up about his life before diagnosis, the challenges he faced in getting answers, and the unique struggles he's encountered as a man living with this chronic illness. He offers an unfiltered look at the realities of male lupus, from the physical and emotional toll to the societal stigma that often accompanies it. His story is one of resilience and hope, highlighting the importance of support, understanding, and connection. This powerful interview also inadvertently demonstrates the rich insights and potential benefits available to the pharmaceutical and healthcare industries when genuine interpersonal rapport is established with patients. Join us for this important conversation as we shed light on male lupus and amplify the voices that need to be heard. When people want to talk, you let them. #Lupus #MaleLupus #ChronicIllness #AutoimmuneDisease #InvisibleIllness #HealthStigma #PatientStories #PatientExperience #HealthAdvocacy #LupusAwareness #MenHealth #ChronicPain #FDA #pharma #clinicaltrials #trials #clinicalresearch #patientperspective #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalPodcast #RareDisease #AutoimmuneAwareness #HealthJourney #Resilience #Support #Understanding #lupusstrong

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

This episode of No Ordinary Subjects offers a deeply personal reflection from your host. I'm Allison Kalloo and I decided to share a powerful encounter that has shaped her understanding of bias in research. Taking a trip down memory lane, I recountsan experience that underscores the fundamental biases that can hinder researchers and their work from achieving true greatness and inclusivity. Rather than dwelling on the problem, this episode offers a valuable teachable moment. It serves as a reminder that moving beyond the limitations of our cultural comfort zones requires stepping down from the 'ivory tower' and actively getting out of our own way. Join me as I explore this critical issue and offer insights on how we can create a more equitable and representative research landscape. #ClinicalTrials #BiasInResearch #HealthEquity #DiversityInResearch #ResearchBias #InclusionInResearch #FDA #IRB #NIH #Congress #HealthPolicy #HealthDisparities #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #PatientExperience #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthInnovation #ResearchEthics #EquityInHealth

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch

Stepping out of the long shadows of myths, misconceptions, and misalignment, No Ordinary Subjects connects the dots and clears a path toward better outcomes in clinical trials – for everyone involved. The status quo is not acceptable, and it's simply not working. It's time to put the pedal down and explore meaningful solutions for all stakeholders in this vital ecosystem: clinical researchers, biopharma, regulatory agencies, CROs, clinical sites and their dedicated staff – with a laser focus on the implications for and impact on study participants, particularly those who have been historically underrepresented in clinical trials.

Join host Allison Kalloo, who has a vested interest in the conversation, the process, and the outcomes, as she embarks on this crucial journey. This premiere episode lays the groundwork for a series of thought-provoking discussions that challenge the status quo and champion innovative approaches to clinical research. Allison believes, and we believe, that you have a vested interest in these conversations too. What topics are most important to you? Reach out and let us know! Let's shape the future of clinical trials together. #ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions

Send us a text

#ClinicalTrials #HealthEquity #DiversityInResearch #UnderrepresentedCommunities #ClinicalResearch #Biopharma #RegulatoryAgencies #CROs #PatientAdvocacy #HealthInnovation #NoOrdinarySubjects #Podcast #HealthPodcast #MedicalResearch #ClinicalResearch #InclusionInResearch #HealthDisparities #PrecisionMedicine #PersonalizedMedicine #PatientCentricity #ResearchEthics #FDA #NIH #EquityInHealth #ChangeTheStatusQuo #MeaningfulSolutions #DEIinHealthcare #HealthDisparities #InclusionInResearch #PatientAdvocacy #PatientStories #HealthPolicy #HealthInnovation #Biotech #Pharmaceuticals #MedicalPodcast #EquityInHealth #RepresentationMatters #UnconsciousBias #CulturalCompetency #HealthJustice #ResearchEthics #UnderrepresentedCommunities #HealthOutcomes #ClinicalCare #HealthResearch